Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Secondary Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel metal-free catalyst technology enabling high-purity chiral secondary amines with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Pd/C catalytic method ensures high purity and yield. Reduces steps for pharmaceutical intermediate manufacturing. Reliable supply chain partner.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.